Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8878)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 21, 2015 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang T, Lau WY, Zhang H, Huang B, Lu JH, Wu MC. Grey zone in the Barcelona Clinic Liver Cancer Classification for hepatocellular carcinoma: Surgeons’ perspective. World J Gastroenterol 2015; 21(27): 8256-8261 [PMID: 26217077 DOI: 10.3748/wjg.v21.i27.8256] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i27/8256.htm |
| Number | Citing Articles |
| 1 |
Dan-Yun Ruan, Ze-Xiao Lin, Tian-Tian Wang, Hui Zhao, Dong-Hao Wu, Jie Chen, Min Dong, Qu Lin, Xiang-Yuan Wu, Yang Li. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1. Oncotarget 2016; 7(38): 61378 doi: 10.18632/oncotarget.11358
|
| 2 |
Yongjiang Li, Yangxun Pan, Ximeng Lin, Jingyu Hou, Zili Hu, Li Xu, Zhongguo Zhou, Yaojun Zhang, Minshan Chen, Dandan Hu. Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score. Frontiers in Pharmacology 2022; 12 doi: 10.3389/fphar.2021.819985
|
| 3 |
|
| 4 |
A. Bauschke, A. Altendorf-Hofmann, C. Malessa, S. Schüle, J. Zanow, U. Settmacher. Which factors affect the long-term survival of patients with hepatocellular carcinoma UICC stage IV?. Journal of Cancer Research and Clinical Oncology 2016; 142(12): 2593 doi: 10.1007/s00432-016-2260-y
|
| 5 |
Jian-Hong Zhong, Guido Torzilli, Hao Xing, Chao Li, Jun Han, Lei Liang, Han Zhang, Shu-Yang Dai, Le-Qun Li, Feng Shen, Tian Yang. Controversies and evidence of hepatic resection for hepatocellular carcinoma. BBA Clinical 2016; 6: 125 doi: 10.1016/j.bbacli.2016.10.001
|
| 6 |
Tian Yang, Han Zhang, Jun Han, Meng‐Chao Wu, Feng Shen. Reply. Hepatology 2017; 65(5): 1773 doi: 10.1002/hep.28980
|
| 7 |
Marco Maccauro, Gianluca Aliberti, Carlo Chiesa, Carlo Spreafico. Clinical Applications of Nuclear Medicine Targeted Therapy. 2018; : 119 doi: 10.1007/978-3-319-63067-0_11
|
| 8 |
Sameh A Lashen, Mohamed M Elshafei, Fahmy H Hablass, Eman A Alsayed, Asmaa A Hassan. Liver stiffness as a predictor of hepatocellular carcinoma behavior in patients with hepatitis C related liver cirrhosis. Hepatobiliary & Pancreatic Diseases International 2020; 19(1): 22 doi: 10.1016/j.hbpd.2019.11.004
|
| 9 |
R. K. Tannus, S. R. Almeida-Carvalho, C. A. Loureiro-Matos, A. Miziara-Gonzalez, A. A. Salzedas-Netto, D. Szejnfeld, G. D'Ippolito, V. Pereira-Lanzoni, I. Souza-Silva, Ferruccio Bonino. Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems. PLOS ONE 2018; 13(4): e0194922 doi: 10.1371/journal.pone.0194922
|
| 10 |
Monica M. Matsumoto, Samdeep Mouli, Priyali Saxena, Ahmed Gabr, Ahsun Riaz, Laura Kulik, Daniel Ganger, Haripriya Maddur, Justin Boike, Steven Flamm, Christopher Moore, Aparna Kalyan, Kush Desai, Bartley Thornburg, Michael Abecassis, Ryan Hickey, Juan Caicedo, Karen Grace, Robert J. Lewandowski, Riad Salem. Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient Analysis. CardioVascular and Interventional Radiology 2021; 44(7): 1070 doi: 10.1007/s00270-021-02810-8
|
| 11 |
Gill Al-Kadhimi. Hepatocellular carcinoma: management of a complex and challenging condition. Gastrointestinal Nursing 2015; 13(Sup10): S20 doi: 10.12968/gasn.2015.13.Sup10.S20
|
| 12 |
Zhu-Jian Deng, Le Li, Yu-Xian Teng, Yu-Qi Zhang, Yu-Xin Zhang, Hao-Tian Liu, Jian-Li Huang, Zhen-Xiu Liu, Liang Ma, Jian-Hong Zhong. Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy. Journal of Clinical and Translational Hepatology 2022; 10(1): 147 doi: 10.14218/JCTH.2021.00179
|
| 13 |
Wen-Tao Yan, Bing Quan, Jiong-Jie Yu, Tian Yang. Should we invariably follow the current guidelines to treat our HCC patients?. Hepatobiliary & Pancreatic Diseases International 2019; 18(3): 301 doi: 10.1016/j.hbpd.2019.01.005
|